Consun Pharmaceutical Group Limited
HKEX:1681.HK
8.51 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 863.703 | 682.907 | 590.172 | 498.788 | 79.82 | 465.353 | 396.242 | 307.526 | 249.689 | 211.2 | 152.882 | 179.062 |
| Depreciation & Amortization
| 78.089 | 76.355 | 72.989 | 71.795 | 73.115 | 68.383 | 64.028 | 39.071 | 18.589 | 15.23 | 12.314 | 11.714 |
| Deferred Income Tax
| 0 | -57.183 | -98.063 | -288.117 | -41.491 | -63.301 | 451.694 | 80.324 | 118.928 | -41.338 | 0 | 0 |
| Stock Based Compensation
| 0 | -1.784 | 23.411 | 12.165 | 19.92 | 8.49 | 21.187 | 22.494 | 35.318 | 47.633 | 0 | 0 |
| Change In Working Capital
| -29.669 | 58.967 | 74.652 | 275.952 | 21.571 | 54.811 | -472.881 | -102.818 | -154.246 | -6.295 | -2.068 | -10.989 |
| Accounts Receivables
| -1.707 | 113.871 | 114.207 | 304.456 | 25.599 | 67.845 | -412.869 | -128.25 | -136.548 | -1.779 | 24.456 | 0 |
| Inventory
| -102.02 | -54.904 | -39.555 | -28.504 | -4.028 | -13.034 | -60.012 | 25.432 | -17.698 | -4.516 | -26.524 | -2.082 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -6.24 | 3.001 | 18.04 | -9.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.907 |
| Other Non Cash Items
| -47.653 | 188.417 | 62.376 | 296.475 | 230.38 | 220.474 | 243.547 | 182.904 | 34.693 | 26.953 | 0.482 | -50.955 |
| Operating Cash Flow
| 818.973 | 947.679 | 725.537 | 867.058 | 383.315 | 754.21 | 252.123 | 449.177 | 184.043 | 294.721 | 163.61 | 128.832 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -52.564 | -51.589 | -98.25 | -48.703 | -179.746 | -193.348 | -54.969 | -25.028 | -17.281 | -20.972 | -64.085 | -37.334 |
| Acquisitions Net
| 0 | 365.672 | 230 | 0 | 0 | 0 | 0 | 134.035 | -641.342 | 0 | 0 | 0 |
| Purchases Of Investments
| -557.5 | -465.672 | -350 | 0 | 0 | 0 | 0 | 0 | -62.458 | -250.9 | 0 | 0 |
| Sales Maturities Of Investments
| 309.23 | 100 | 120 | 0 | 0 | 0 | 0 | 0 | 250.9 | 0 | 0 | 0 |
| Other Investing Activites
| -179.208 | -317.215 | -200.055 | 23 | 69.614 | 12.544 | -5.08 | -17.119 | 14.375 | 23.593 | 80.363 | -74.13 |
| Investing Cash Flow
| -231.772 | -368.804 | -298.305 | -25.703 | -110.132 | -180.804 | -60.049 | 91.888 | -455.806 | -248.279 | 16.278 | -111.464 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 62.969 | -177.352 | 62.838 | 25.833 | 147.489 | -197.008 | 594.641 | -90 | 0 | 0 | 0 | -13.6 |
| Common Stock Issued
| 14.202 | 2.638 | 14.567 | 0 | 2.491 | 5.624 | 244.371 | 0 | 0 | 0 | 852.925 | 14.028 |
| Common Stock Repurchased
| 0 | -29.066 | -30.151 | -152.745 | -46.212 | 0 | -505.716 | -81.132 | -8.84 | 0 | 0 | 0 |
| Dividends Paid
| -326.249 | -127.492 | -198.078 | -131.491 | -225.546 | -68.943 | -173.231 | -114.512 | -28 | -38 | -181.907 | -0.912 |
| Other Financing Activities
| -16.82 | -10.933 | -15.835 | -21.401 | -34.884 | -32.098 | -31.94 | -72.697 | -0.441 | -21.44 | -30.635 | 0 |
| Financing Cash Flow
| -280.1 | -342.205 | -166.659 | -279.804 | -156.662 | -292.425 | 128.125 | -358.341 | -81.919 | -104.799 | 640.383 | -0.484 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -9.012 | 17.18 | -4.523 | -4.51 | -3.035 | -0.8 | -3.345 | 0 | 0 | 0 | 81.755 | 0 |
| Net Change In Cash
| 298.089 | 253.85 | 256.05 | 557.041 | 113.486 | 280.181 | 316.854 | 182.724 | -353.682 | -58.357 | 902.026 | 16.884 |
| Cash At End Of Period
| 2,748.262 | 2,450.173 | 2,196.323 | 1,940.273 | 1,383.232 | 1,269.746 | 989.565 | 672.711 | 489.987 | 843.669 | 902.026 | 81.755 |